Evidence map›Paper›PMID 31967271›Full record

ArticleJornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia

Tumor-node-metastasis staging and treatment patterns of 73,167 patients with lung cancer in Brazil.

Guilherme Jorge Costa, Maria Júlia Gonçalves de Mello, Anke Bergmann, Carlos Gil Ferreira, Luiz Claudio Santos Thuler

Open access · diamondAbstract read
In one paragraph

Article in Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. External validation of the parsimonious EuroLung risk models: analysis of the Brazilian Lung Cancer Registry.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Lung cancer staging in Brazil: an epidemiological perspective.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Guilherme Jorge Costa. Departamento de Ensino e Pesquisa, Hospital de Câncer de Pernambuco, Recife (PE) Brasil.ORCID http://orcid.org/0000-0002-3699-0590
Maria Júlia Gonçalves de Mello. Departamento de Pesquisa Clínica, Instituto de Medicina Integral Professor Fernando Figueira, Recife (PE) Brasil.ORCID http://orcid.org/0000-0003-4645-8343
Anke Bergmann. Instituto Nacional de Câncer José Alencar Gomes da Silva, Divisão de Pesquisa Clínica e Programa de Pós-Graduação em Oncologia, Rio de Janeiro (RJ) Brasil.ORCID http://orcid.org/0000-0002-1972-8777
Carlos Gil Ferreira. Instituto Oncoclíncas, Rio de Janeiro (RJ) Brasil.ORCID http://orcid.org/0000-0002-7228-7018
Luiz Claudio Santos Thuler. Instituto Nacional de Câncer José Alencar Gomes da Silva, Divisão de Pesquisa Clínica e Programa de Pós-Graduação em Oncologia, Rio de Janeiro (RJ) Brasil.ORCID http://orcid.org/0000-0003-2550-6537
Instituto Nacional de Câncer - INCA · BRFundação Instituto de Pesca do Estado do Rio de Janeiro · BRHospital de Câncer de Pernambuco · BRInstituto de Medicina Integral Professor Fernando Figueira · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo characterize the clinical and histological profile, as well as treatment patterns, of patients with early-stage, locally advanced (LA), or advanced/metastatic (AM) lung cancer, diagnosed between 2000 and 2014, in Brazil.

methodsThis was an analytical cross-sectional epidemiological study employing data obtained for the 2000-2014 period from the hospital cancer registries of two institutions in Brazil: the José Alencar Gomes da Silva National Cancer Institute, in the city of Rio de Janeiro; and the São Paulo Cancer Center Foundation, in the city of São Paulo.

resultsWe reviewed the data related to 73,167 patients with lung cancer. The proportions of patients with early-stage, LA, and AM lung cancer were 13.3%, 33.2%, and 53.4%, respectively. The patients with early-stage lung cancer were older and were most likely to receive a histological diagnosis of adenocarcinoma; the proportion of patients with early-stage lung cancer remained stable throughout the study period. In those with LA lung cancer, squamous cell carcinoma predominated, and the proportion of patients with LA lung cancer decreased significantly over the period analyzed. Those with AM lung cancer were younger and were most likely to have adenocarcinoma; the proportion of patients with AM lung cancer increased significantly during the study period. Small cell carcinoma accounted for 9.2% of all cases. In our patient sample, the main treatment modality was chemotherapy.

conclusionsIt is noteworthy that the frequency of AM lung cancer increased significantly during the study period, whereas that of LA lung cancer decreased significantly and that of early-stage lung cancer remained stable. Cancer treatment patterns, by stage, were in accordance with international guidelines.

Indexed as

AdolescentAdultAgedAge DistributionBrazilCarcinomaCross-Sectional StudiesFemaleHumansLung NeoplasmsMaleMiddle AgedNeoplasm MetastasisNeoplasm StagingPrevalenceSex Distribution

Identifiers

PMID31967271
PMCPMC7462681
OpenAlexW3001051782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.